A new era of biomedical discovery
A new era of biomedical discovery
Biomedical discovery is moving faster than ever. Yet, progress against complex disease is limited by an age-old challenge: How do we turn discoveries into insights that are reliable, reproducible, and truly relevant to human biology? Too often, translation science remains slow, costly, and uncertain.
With the acquisition of The New York Stem Cell Foundation (NYSCF), The Jackson Laboratory (JAX) is advancing a bold new model for biomedical research — one that seamlessly connects the power of mouse, cell, and computational systems to accelerate progress from discovery to therapy.
This expanded platform brings together JAX’s global leadership in mouse genetics and preclinical modeling with NYSCF’s world-class expertise in stem cell science, automation, and high-throughput discovery. Combined with AI-powered data analysis, these strengths form an integrated discovery engine that enables scientists to reveal disease mechanisms earlier and test therapies with greater precision.
Together, we are transforming what’s possible for researchers and the patients whose lives depend on discovery — turning possibility into progress.
Featured in Search
Search magazine is a publication from The Jackson Laboratory focused on research discoveries and human health.